PG-3113

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NamePG-3113
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantationLupus Erythematosus, SystemicArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmagenesis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmagenesis
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationLupus Erythematosus, SystemicArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A